These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37537250)

  • 1. Increased incidence of teicoplanin-non-susceptible Staphylococcus epidermidis strains: a 6-year retrospective study.
    Kim S; Choi JP; Oh DH; Ahn MY; Yang E
    Sci Rep; 2023 Aug; 13(1):12582. PubMed ID: 37537250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
    Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
    Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous glycopeptide intermediate Staphylococcus epidermidis isolated from prosthetic joint infections.
    Tevell S; Claesson C; Hellmark B; Söderquist B; Nilsdotter-Augustinsson Å
    Eur J Clin Microbiol Infect Dis; 2014 Jun; 33(6):911-7. PubMed ID: 24338092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides.
    Del' Alamo L; Cereda RF; Tosin I; Miranda EA; Sader HS
    Diagn Microbiol Infect Dis; 1999 Jul; 34(3):185-91. PubMed ID: 10403098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro characteristics of glycopeptide resistant strains of Staphylococcus epidermidis isolated from patients on CAPD.
    Sanyal D; Johnson AP; George RC; Edwards R; Greenwood D
    J Antimicrob Chemother; 1993 Aug; 32(2):267-78. PubMed ID: 8226428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycopeptide resistance in coagulase-negative staphylococci.
    Biavasco F; Vignaroli C; Varaldo PE
    Eur J Clin Microbiol Infect Dis; 2000 Jun; 19(6):403-17. PubMed ID: 10947214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative Staphylococci isolated from orthopedic-device-associated infections.
    Cremniter J; Slassi A; Quincampoix JC; Sivadon-Tardy V; Bauer T; Porcher R; Lortat-Jacob A; Piriou P; Judet T; Herrmann JL; Gaillard JL; Rottman M
    J Clin Microbiol; 2010 Apr; 48(4):1428-31. PubMed ID: 20164270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between daptomycin susceptibility and teicoplanin resistance in Staphylococcus epidermidis.
    Watanabe S; Kawakami Y; Kimura H; Murakami S; Miyamoto H; Takatori S; Suemori K; Tanaka M; Tanaka A; Tanaka K; Tauchi H; Maki J; Araki H; Yamaguchi T
    Sci Rep; 2019 Dec; 9(1):18533. PubMed ID: 31811214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of Teicoplanin Nonsusceptible Staphylococcus epidermidis Clinical Isolates Belonging Predominantly to ST267.
    Liu C; Zhang F; Chen C; Feng X; Xu M; Guo X; Sun J; Li G; Zhu P; Zeng L; Xu H; Wang H; Li X; Ming L
    Microb Drug Resist; 2017 Apr; 23(3):321-327. PubMed ID: 27314582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro susceptibilities of clinical isolates of coagulase-negative staphylococci to glycopeptide antibiotics].
    Kato D; Hanaki H; Cui L; Oguri T; Hiramatsu K
    Jpn J Antibiot; 1998 Dec; 51(12):735-45. PubMed ID: 10077772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycopeptide susceptibility profiles of nosocomial multiresistant Staphylococcus haemolyticus isolates.
    Tabe Y; Nakamura A; Igari J
    J Infect Chemother; 2001 Sep; 7(3):142-7. PubMed ID: 11810575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycopeptide susceptibility profiles of Staphylococcus haemolyticus bloodstream isolates.
    Biavasco F; Vignaroli C; Lazzarini R; Varaldo PE
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3122-6. PubMed ID: 11036034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inefficacy of vancomycin and teicoplanin in eradicating and killing Staphylococcus epidermidis biofilms in vitro.
    Claessens J; Roriz M; Merckx R; Baatsen P; Van Mellaert L; Van Eldere J
    Int J Antimicrob Agents; 2015 Apr; 45(4):368-75. PubMed ID: 25614358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro selection of resistance to vancomycin and teicoplanin in Enterococcus faecium and Enterococcus faecalis compared with Staphylococcus epidermidis.
    Markopulos E; Graninger W; Georgopoulos A
    J Antimicrob Chemother; 1998 Jan; 41(1):43-7. PubMed ID: 9511036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing susceptibilities of coagulase-negative staphylococci to teicoplanin in a teaching hospital.
    Sloos JH; van de Klundert JA; Dijkshoorn L; van Boven CP
    J Antimicrob Chemother; 1998 Dec; 42(6):787-91. PubMed ID: 10052903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emergence of Staphylococcus epidermidis simultaneously nonsusceptible to linezolid and teicoplanin in China.
    Liu C; Chen C; Ye Y; Li X; Sun J; Xu L; Ming L
    Diagn Microbiol Infect Dis; 2020 Feb; 96(2):114956. PubMed ID: 31813640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Draft genome sequences of three clinical isolates of teicoplanin-resistant Staphylococcus epidermidis from patients without prior exposure to glycopeptide antibiotics.
    Vimberg V; Zieglerova L; Závora J; Šemberová L; Prásilová J; Adámková V; Novotna GB
    J Glob Antimicrob Resist; 2019 Mar; 16():251-253. PubMed ID: 30797086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations.
    Low DE; McGeer A; Poon R
    Antimicrob Agents Chemother; 1989 Apr; 33(4):585-8. PubMed ID: 2543286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of aptamer targeted teicoplanin encapsulated PLGA nanoparticles for Staphylococcus aureus strains.
    Ucak S; Sudagidan M; Borsa BA; Mansuroglu B; Ozalp VC
    World J Microbiol Biotechnol; 2020 Apr; 36(5):69. PubMed ID: 32333113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antibacterial activity of LY333328, a new semisynthetic glycopeptide.
    Biavasco F; Vignaroli C; Lupidi R; Manso E; Facinelli B; Varaldo PE
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2165-72. PubMed ID: 9333042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.